Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Short-term Fat Overfeeding on the Effects of Liver Metabolism

The Effect of Short-term Overconsumption of Specific Dietary Nutrients on Liver and Adipose Tissue Metabolism.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Despite work showing the overconsumption of saturated fatty acids (SFA) to be metabolically deleterious, debate continues about whether there is a link between SFA and cardiovascular disease risk. To explore this, we are undertaking a human in vivo parallel-design study, comparing two isocaloric high-fat diets; one enriched with SFA and the other enriched with unsaturated fatty acids (UFAs), to determine the impact of dietary fat composition on postprandial metabolism, liver fat, cardiac fat and cardiac function.

Who May Be Eligible (Plain English)

Who May Qualify: - The participant is willing and able to give willing to sign a consent form for participation in the study. - Male or Female, aged ≥18 or ≤65 years. - Body Mass Index ≥19 ≤35 kg/m2 - No medical condition or relevant drug therapy that is known to affect liver or adipose tissue metabolism. - Weight stable for the previous 3 months Who Should NOT Join This Trial: - The participant is unwilling or unable to give willing to sign a consent form for participation in the study. - Aged ≤18 or ≥65 years - Body Mass Index ≤19 or ≥35kg/m2 - Blood haemoglobin \<135mg/dL for men and \<120mg/dL for women - Donated (or lost) ≥250 ml of blood in the previous two months. - On a weight loss diet or have decreased their body weight by \>5% in the previous 3 months. - Have increased their body weight by \>5% in the previous 3 months. - Any metabolic condition or relevant drug therapy - Current smoker - History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women) - Haemorrhagic disorders - Anticoagulant treatment - History of albumin allergy - Pregnant or nursing mothers - Women prescribed any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months History of severe claustrophobia - Presence of metallic implants, pacemakers, or are unwilling to remove any piercings - History of an eating disorder or any other psychological condition that may affect the participant's ability to adhere to study intervention/experimental diets. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * The participant is willing and able to give informed consent for participation in the study. * Male or Female, aged ≥18 or ≤65 years. * Body Mass Index ≥19 ≤35 kg/m2 * No medical condition or relevant drug therapy that is known to affect liver or adipose tissue metabolism. * Weight stable for the previous 3 months Exclusion Criteria: * The participant is unwilling or unable to give informed consent for participation in the study. - Aged ≤18 or ≥65 years * Body Mass Index ≤19 or ≥35kg/m2 * Blood haemoglobin \<135mg/dL for men and \<120mg/dL for women * Donated (or lost) ≥250 ml of blood in the previous two months. * On a weight loss diet or have decreased their body weight by \>5% in the previous 3 months. * Have increased their body weight by \>5% in the previous 3 months. * Any metabolic condition or relevant drug therapy * Current smoker * History of alcoholism or a greater than recommended alcohol intake (\>30 g of alcohol daily for men and \>20 g of alcohol daily for women) * Haemorrhagic disorders * Anticoagulant treatment * History of albumin allergy * Pregnant or nursing mothers * Women prescribed any contraceptive agent or device including oral contraceptives, hormone replacement therapy (HRT) or who have used these within the last 12 months History of severe claustrophobia * Presence of metallic implants, pacemakers, or are unwilling to remove any piercings * History of an eating disorder or any other psychological condition that may affect the participant's ability to adhere to study intervention/experimental diets.

Treatments Being Tested

BEHAVIORAL

Diet

High fat (\~60% of total energy intake) diet enriched with either SFA or UFA

Locations (1)

Oxford Centre for Diabetes, Endocrinology and Metabolism
Oxford, United Kingdom